We invited Sarah Roth to join us for a Conversation That Matters about the many research projects underway in British Columbia that will help us defeat cancer.

We invited Dr Hogg to join us for a Conversation That Matters about the role genomics is playing in an all-out effort to save the Tasmanian devil.

Stuart McNish invited Dr. Zandstra to join him for a Conversation that Matters about the role his research has played in finding cures for debilitating chronic diseases and the greater life sciences and biomedical community in Vancouver and British Columbia.

Stuart McNish invited Wendy Hurlburt, the President and CEO of LifeSciences BC, to join us for a Conversation That Matter about the remarkable intellectual assets we have in BC and why we need to support them to the benefit of all of us.

We invited Carolyn Cross of Ondine Biomedical to join us for a Conversation That Matters about the laser treatment her company has been developing to reduce surgical site infection rates.

We invited the Pacific Salmon Foundation’s Vice President for Salmon, Jason Hwang, to join us for a Conversation That Matters about the state of salmon.

Dr. Claire Fraser joined us for a Conversation That Matters about you, the organisms you are host to and your relationship with them.

We invited marine scientist Dr Richard Beamish to join us for a Conversation That Matters about the next step forward in understanding where our beloved salmon go and what we can do to help ensure their survival.

We invited Andrew Trites to join us for a Conversation That Matters about what is happening with the Southern Resident Orca Whale population.

We invited Dr Jeremy Burton, the Deputy Director of the Canadian Centre for Human Microbiome and Probiotics, to join us for a Conversation That Matters about the exciting research underway in treating your well-being by re-engineering the bacteria in your intestinal tract.

For Eaves, there are no limits. “We are going for world domination and it’s all working out nicely.”

In 2000, the world of medicine and research was all aflutter with possibility. The human genome project was about to wrap up and we were promised huge health benefits. That was 16 years ago and so far, reality has come up short of the promised potential.

What if you can capture your healthy immune cells, freeze them and then get them back later if you get cancer or some other life threatening disease? That is the vision of Jeff Schulz, who is spearheading a Vancouver based company that wants to do that.